As of today, Amgen Inc. last 12-month Revenue is $30.8 bn , EBITDA is $11.4 bn and Net Income is $3.1 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Amgen Inc. Total Assets are $90.9 bn and Total Liabilities are $85.0 bn , based on the financial report for June 30, 2024 (Q2 2024).
As of today, Amgen Inc. last 12-month Cash Flow from Operating Activities is $2.5 bn, Cash Flow from Investing Activities is $-0.2 bn and Cash Flow from Financing Activities is $-2.6 bn, based on the financial report for June 30, 2024 (Q2 2024).
As of today, Amgen Inc. last 12-month Free Cash Flow is $5.5 bn , based on the financial report for June 30, 2024 (Q2 2024).